Request the white paper “Outsourcing in Pharmacovigilance: Why and How?”

With the development of new technologies and continuous investments in R&D, the pharmaceutical industry displays stable growth for the past years. However, industry growth also brings an increase in the amount of challenges and their complexity. Among them, we could single out two challenges that have the biggest impact:

  • regulatory;
  • digital transformation;

Varying regulations across the globe, product innovation and new technologies heavily affect pharmaceutical companies who have to ensure that they are always aligned, transparent and modern.
One of the most affected functions inside pharmaceutical companies is pharmacovigilance. Growing safety
concerns that result in stricter safety regulations, growing amount of sources of safety signals, and growing
demand for transparency put continuous pressure on the infrastructure. This in turn results in raising costs of its maintenance.

Specialized outsourcing in pharmacovigilance is one possible way of coping with the growing costs of keeping a highly qualified and trained pharmacovigilance team in-house. A well-implemented pharmacovigilance outsourcing program brings noticeable benefits including:

  • Fixed costs become variable costs;
  • Reduction of the number of resources to recruit, manage, and train;
  • Increased flexibility;
  • Improved efficiencies;

However, in order to harness maximum benefits from pharmacovigilance outsourcing companies need to ensure that they make the right decision about the scale of their outsourcing vendor relationship and ensure adequate oversight.

In this white paper our pharmacovigilance professionals are sharing recommendations on how small, mid-sized and big pharmaceutical companies can organize their pharmacovigilance outsourcing in order to achieve the best results. 

Request the White Paper “Outsourcing in Pharmacovigilance: Why and How?”

Name and Surname*

Email*

Your company*

 

Information Marketing

Consent pursuant to art. 6 Regulation (EU) 2016/679

Upon reading the Information Notice outlined above:

a) The undersigned shall give specific consent to the processing of personal data for marketing purposes (namely direct sale, sending of advertising material, market research and commercial communication).
This consent is provided for marketing carried out by using both traditional systems (such as paper mail, phone call with operator) and automated systems of call or communication without operator, email, telefax, short text messages, MMS, or other automated means of communication. The data subject’s right to oppose the processing of their personal data for the purpose of direct marketing through automated contact methods also covers the traditional ones, with the possibility of exercising this right also partially.
The data subject may express their consent to receiving communications for the abovementioned purposes exclusively through traditional methods of contact.
The data subject’s refusal to give consent will result in the company’s failure to process their data for marketing purposes.

 

b) The undersigned shall give specific consent to the processing of their personal data for profiling activities.

 

c) The undersigned shall give specific consent to the processing of their personal data for communicating data to third parties for marketing purposes.

 
 

CategoryBlog
Write a comment:

*

Your email address will not be published.

©2017 - seQure - All Right Reserved - Privacy Policy - Cookie Policy